Gene · 481
NIH grants1,651
NIH grants whose papers are about the gene, through NIH's grant-paper links.
341 to 360 of 1,651
Download this page as JSON| Grant | Title | ATP1B1 papers | Newest fiscal year |
|---|---|---|---|
| R01AG066165 | Overlapping Molecular Dysregulation of Endolysosomal Function in Alzheimer's Disease and FTLD-TDP | 1 | 2023 |
| R01AG069921 | Development of PET imaging probes for ROCK2 | 1 | 2023 |
| R01AI111935 | Autophagy Against Tuberculosis and HIV | 1 | 2023 |
| R01DK103740 | Mechanisms of Successful vs. Failed Kidney Repair | 1 | 2023 |
| R01DK130425 | Experimental and natural SARS-CoV-2 infection of the human pancreas | 1 | 2023 |
| R01ES030950 | Environmental bisphenol exposure, infant brain and behavior: Human and animal models | 1 | 2023 |
| R01GM135362 | Selective mRNA translation in developmental disorders | 1 | 2023 |
| R01HL046716 | Effect of Cardioplegia and Cardiopulmonary Bypass on Coronary Microvascular Reactivity | 1 | 2023 |
| R01HL117247 | Cellular and Circulating Fortilin in Vascular Diseases | 1 | 2023 |
| R01HL125280 | The role of mucus and pulmonary surface interactions in lung defense | 1 | 2023 |
| R01HL145025 | Methods and Software for Large-Scale Gene-Environment Interaction Studies | 1 | 2023 |
| R01HL148218 | Proteomic signatures to identify pathways underlying the progression to heart failure | 1 | 2023 |
| R01HL148825 | A multimodal delivery and treatment approach for Acute Lung Injury | 1 | 2023 |
| R01HL149706 | Proteomic discovery in an inception cohort of acute myocardial infarction survivors | 1 | 2023 |
| R01HL151855 | TOPMed Omics of Cardiovascular Disease in Diabetes | 1 | 2023 |
| R01NS089713 | Structural Basis of Vesicular Neurotransmitter Transport | 1 | 2023 |
| R01NS105755 | Genomic Studies in Charcot-Marie-Tooth Disease | 1 | 2023 |
| R35HL135834 | Mechanisms Controlling Expansion and Lineage Specification of Airway Progenitors in Development and Disease | 1 | 2023 |
| S10OD032433 | High Performance Computing Cluster for Biomedical Research | 1 | 2023 |
| T32DK007545 | Interdisciplinary Training in Kidney-Related Research | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/481/grants?page=18